1 / 7

JSB Market Research: Cebranopadol (Neuropathic Pain)

Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Although the term neuropathic pain is used to describe a wide range of pain syndromes with varying etiologies, this report focuses on 3 distinct forms of NP: Painful diabetic neuropathy, Postherpetic neuralgia and trigeminal neuralgia.

jenniferdsoza
Download Presentation

JSB Market Research: Cebranopadol (Neuropathic Pain)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. JSB Market Research: Cebranopadol (Neuropathic Pain) - Forecast and Market Analysis to 2022 To buy this Report Visit http://www.jsbmarketresearch.com

  2. Summary: Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Although the term neuropathic pain is used to describe a wide range of pain syndromes with varying etiologies, this report focuses on 3 distinct forms of NP: Painful diabetic neuropathy, Postherpetic neuralgia and trigeminal neuralgia. The main classes of drugs used to treat these three neuropathic pain indications include anticonvulsants, antidepressants, opioids and topical treatments.

  3. Key Highlights: • Overview of Neuropathic pain, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. • Detailed information on Cebranopadol including product description, safety and efficacy profiles as well as a SWOT analysis. • Sales forecast for Cebranopadol for the top six countries from 2012 to 2022. • Sales information covered for the US, France, Germany, Italy, Spain and the UK. • To know more about this report click here – • http://www.jsbmarketresearch.com/healthcare-medical/r-Cebranopadol-Neuropathic-Pain-Forecast-and-Market-Analysis-to-2022-114989

  4. Table of Contents: Cebranopadol (Neuropathic Pain) - Forecast and Market Analysis to 2022 Painful Diabetic Neuropathy 16 Postherpetic Neuralgia 17 Trigeminal Neuralgia 17 Etiology and Pathophysiology 18

  5. Related Market Research Report • Global Wheelchair Market to 2018 - Market Size, Growth, and Forecasts in 50 Countries • Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018 • Global Clean Coal Technologies Market 2014-2018 • Global Endometriosis Market 2014-2018

  6. About JSB Market Research • Jsbmarketresearch.com is an online repository of an extensive collection of market research reports available online. This online portal contains high-quality reports with well-researched and high-quality content on a wide range of industries. These market research reports help us give a detailed insight into new opportunities in the industry, prevailing market trends, competitor analysis and future prospects. • JSB’s reports are developed by the domain experts and publishers under a closely observed surveillance of industry specialists. Therefore, the researched data is well researched, well- organized and matching up to the best standards in the industry. Also JSB’s database consists of detailed insights of the leading players in the global market, products and trends.

  7. Contact Us Support & General Inquiries Mail :support@jsbmarketresearch.com | +91 - 998 729 5242 Billing Support Mail :billing@jsbmarketresearch.com | +91 22 412 366 50 Website:-http://www.jsbmarketresearch.com

More Related